ENTX vs IPSC: stock comparison and AI forecast
Entera Bio Ltd. (ENTX) and Century Therapeutics, Inc. (IPSC) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ENTX Entera Bio Ltd.
- Price
- $2.99 +118.2% · 6M
- Market Cap
- $518M
- P/E Ratio
- 9.1x
- Size
- small-cap
- AI Forecast
IPSC Century Therapeutics, Inc.
- Price
- $1.68 -27.3% · 6M
- Market Cap
- $304M
- P/E Ratio
- 24.0x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ENTX is 1.7 times larger than IPSC by market capitalization ($518M against $304M).
- ENTX trades at 9.1 times trailing earnings, IPSC at 24.0 times.
- Over the last six months ENTX returned +118.2% and IPSC -27.3%.
- ENTX carries 1.68 times debt per unit of equity, against 0.24 times for IPSC.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ENTX | IPSC |
|---|---|---|
| Market Cap | $518M | $304M |
| P/E Ratio | 9.06x | 24.00x |
| P/B Ratio | 71.25x | 1.31x |
| EPS | $0.33 | $0.07 |
| Book Value/Share | $0.04 | $1.28 |
| Revenue/Share | $0.00 | – |
| FCF/Share | $-0.06 | $-0.49 |
Profitability & Margins
| Metric | ENTX | IPSC |
|---|---|---|
| ROIC | -82.9% | -43.0% |
| Operating Margin | – | 53.6% |
| EBT Margin | – | 41.3% |
| Tax Rate | – | -1.9% |
Financial Health
| Metric | ENTX | IPSC |
|---|---|---|
| Current Ratio | 8.98x | 8.28x |
| D/E Ratio | 1.68x | 0.24x |
| Financial Leverage | 2.68x | 1.24x |
| Interest Coverage | – | -257.9x |
| Working Capital | $17M | $110M |
Cash Flow
| Metric | ENTX | IPSC |
|---|---|---|
| Operating Cash Flow | -$11M | -$87M |
| Free Cash Flow | -$11M | -$88M |
| Capital Spending | -$70K | -$1M |
Operational Efficiency
| Metric | ENTX | IPSC |
|---|---|---|
| Asset Turnover | 0.00x | – |
| Fixed Assets Turnover | 0.0x | – |
Income Statement
| Metric | ENTX | IPSC |
|---|---|---|
| Total Revenue | $0.00M | – |
| Operating Income | -$14M | -$117M |
| R&D Expense | $9M | $79M |
| SG&A Expense | $550K | – |
| Cost of Goods Sold | $0.00M | – |
Dividend & Shareholder Information
| Metric | ENTX | IPSC |
|---|---|---|
| Shares Outstanding | 173M | 181M |
| EPS Growth | 32.0% | – |
ENTX vs IPSC: stock comparison and AI forecast
Which is bigger, ENTX or IPSC?
ENTX is 1.7 times larger than IPSC by market capitalization ($518M against $304M).
Which is cheaper on earnings, ENTX or IPSC?
ENTX trades at 9.1 times trailing earnings, IPSC at 24.0 times.
Which stock performed better over the last six months, ENTX or IPSC?
Over the last six months ENTX returned +118.2% and IPSC -27.3%.
Which one does Intratio's AI model rank higher, ENTX or IPSC?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.